Key Financial Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Key Financial Inc’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$144K	Hold	290	–	–	0.02%	360
2026 Q1	$129K	Hold	290	–	–	0.02%	362
2025 Q4	$131K	Hold	290	–	–	0.02%	352
2025 Q3	$117K	Hold	290	–	–	0.02%	367
2025 Q2	$129K	Hold	290	–	–	0.03%	342
2025 Q1	$141K	Sell	290 -16	-5%	-$7.46K	0.03%	311
2024 Q4	$123K	Buy	306 +16	+6%	+$7.42K	0.03%	320
2024 Q3	$135K	Sell	290 -11	-4%	-$5.28K	0.03%	298
2024 Q2	$141K	Buy	301 +251	+502%	+$109K	0.03%	276
2024 Q1	$20.9K	Hold	50	–	–	0.01%	602
2023 Q4	$20.3K	Hold	50	–	–	0.01%	586
2023 Q3	$17.4K	Hold	50	–	–	0.01%	595
2023 Q2	$17.6K	Buy	50 +32	+178%	+$10.8K	0.01%	602
2023 Q1	$5.67K	Hold	18	–	–	﹤0.01%	801
2022 Q4	$5.21K	Hold	18	–	–	﹤0.01%	785
2022 Q3	$5K	Hold	18	–	–	﹤0.01%	810
2022 Q2	$5K	Hold	18	–	–	﹤0.01%	817
2022 Q1	$5K	Hold	18	–	–	﹤0.01%	809
2021 Q4	$4K	Buy	+18	New	+$3.5K	﹤0.01%	761

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Key Financial Inc's VRTX Position: Q2 2026 in Review

Key Financial Inc held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 290 shares worth $144K. The position accounts for 0.02% of the portfolio, ranked #360.

Key Financial Inc first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Key Financial Inc held 290 shares of Vertex Pharmaceuticals worth $144K as of Q2 2026.
Key Financial Inc left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.02% of Key Financial Inc's portfolio in Q2 2026, its #360 holding.
Key Financial Inc first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.